News &
Announcements

Emerging Therapy Solutions was proud to support the conversations helping payers, employers and risk partners prepare for what’s ahead at the 2026 MCRA (Managed Care Risk Association) Annual Conference.

One of those conversations was led by Ashley Hume, CEO of ETS, during her Sept. 16 session: “Managing the Unmanageable: Cell & Gene Therapy Risk in a Rapidly Evolving Market”.

Drawing on ETS’s decades of experience helping organizations navigate high-cost, complex care, Ashley shared what ETS has learned about anticipating cell and gene therapy exposure, evaluating financial risk and preparing before a claim occurs.